Oryzon Genomics. (0RDB.LSE) Q1 2026 Earnings

Feb 27Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.03
-0.02
-0.01
0

Details

Expected EPS
-0.034202126657517
Actual EPS
-0.01987975626
Surprise EPS
0.01
Surprise Percent
+41.88%

Description

⁨Oryzon Genomics.⁩ (⁦0RDB.LSE⁩) has reported earnings of ⁦-0.01987975626⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts